BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 956340)

  • 61. Osteoporosis in ovarian dysgenesis.
    Brown DM; Jowsey J; Bradford DS
    J Pediatr; 1974 Jun; 84(6):816-20. PubMed ID: 4826614
    [No Abstract]   [Full Text] [Related]  

  • 62. Bone mineral and calcium metabolism before, during and after treatment of osteoporosis with 1 alpha-hydroxyvitamin D3 and calcium.
    Lindholm TS; Eriksson S
    Scand J Rheumatol; 1982; 11(1):55-7. PubMed ID: 7063813
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Serum alkaline phosphatase during hormone treatment in early postmenopausal women. A model for establishing optimal prophylaxis and treatment in postmenopausal osteoporosis.
    Christiansen C; Rødbro P; Tjellesen L
    Acta Med Scand; 1984; 216(1):11-7. PubMed ID: 6385631
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Actual concept of osteoporosis in paraplegia.
    Chantraine A
    Paraplegia; 1978 May; 16(1):51-8. PubMed ID: 733286
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Experimental studies on osteoporosis.
    Krook L; Whalen JP; Lesser GV; Berens DL
    Methods Achiev Exp Pathol; 1975; 7():72-108. PubMed ID: 1105064
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Bone, calcium, and hydroxyproline metabolism in hyperparathyroidism and after removal of parathyroid adenoma.
    Laitinen O
    Acta Med Scand; 1977; 202(1-2):39-42. PubMed ID: 899881
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis.
    Brown JP; Delmas PD; Malaval L; Edouard C; Chapuy MC; Meunier PJ
    Lancet; 1984 May; 1(8386):1091-3. PubMed ID: 6144827
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Postmenopausal and senile osteoporosis: current concepts of etiology and treatment.
    Riggs BL
    Endocrinol Jpn; 1979 Jun; 26(Suppl):31-41. PubMed ID: 467347
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Short-term effects of synthetic human parathyroid hormone-(1--34) administration on bone mineral metabolism in osteoporotic patients.
    Slovik DM; Neer RM; Potts JT
    J Clin Invest; 1981 Nov; 68(5):1261-71. PubMed ID: 7298851
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Basal plasma immunoreactive calcitonin in postmenopausal osteoporosis.
    Chesnut CH; Baylink DJ; Sisom K; Nelp WB; Roos BA
    Metabolism; 1980 Jun; 29(6):559-62. PubMed ID: 7382823
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Treatment of osteoporosis of ageing with 1alpha-hydroxycholecalciferol.
    Lund B; Hjorth L; Kjaer I; Reimann I; Friis T; Andersen RB; Sorensen OH
    Lancet; 1975 Dec; 2(7946):1168-71. PubMed ID: 53656
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Acute changes in calcium and bone metabolism during methylprednisolone pulse therapy in rheumatoid arthritis.
    Bijlsma JW; Duursma SA; Bosch R; Raymakers JA; Huber-Bruning O
    Br J Rheumatol; 1988 Jun; 27(3):215-9. PubMed ID: 3378125
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of growth hormone in osteoporosis.
    Aloia JF; Zanzi I; Ellis K; Jowsey J; Roginsky M; Wallach S; Cohn SH
    J Clin Endocrinol Metab; 1976 Nov; 43(5):992-9. PubMed ID: 993324
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The hormonal form of vitamin D in the pathophysiology and therapy of postmenopausal osteoporosis.
    Caniggia A; Nuti R; Loré F; Vattimo A
    J Endocrinol Invest; 1984 Aug; 7(4):373-8. PubMed ID: 6094649
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Design and data quality of a mixed longitudinal study to elucidate the role of dietary calcium and phosphorus on bone mineralization in pre-, peri-, and postmenopausal women.
    van Beresteyn EC; van 't Hof MA; de Waard H; Dekker PR; Neeter R; Winkeldermaat HJ; Visser RM; Schaafsma G; van Schiak M; Duursma SA
    Am J Clin Nutr; 1986 Apr; 43(4):538-48. PubMed ID: 3962907
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Lack of hormonal changes in postmenopausal women of equal weight with and without osteoporosis, including relation to time of menopause.
    Rico H; Charro A; Depablos I; Bordiu E; Hernandez ER; Espinos D
    Clin Rheumatol; 1984 Sep; 3(3):337-43. PubMed ID: 6488712
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Nonosteomalacic osteopathy associated with chronic hypophosphatemia.
    de Vernejoul MC; Marie P; Kuntz D; Gueris J; Miravet L; Ryckewaert A
    Calcif Tissue Int; 1982 May; 34(3):219-23. PubMed ID: 6809281
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Calcium metabolism in the young adult male as affected by level and form of phosphorus intake and level of calcium intake.
    Zemel MB; Linkswiler HM
    J Nutr; 1981 Feb; 111(2):315-24. PubMed ID: 6257868
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Dietary phosphorus, PTH, and bone resorption.
    Nutr Rev; 1973 Apr; 31(4):124-6. PubMed ID: 4578895
    [No Abstract]   [Full Text] [Related]  

  • 80. Effects of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humans.
    Gennari C; Imbimbo B; Montagnani M; Bernini M; Nardi P; Avioli LV
    Calcif Tissue Int; 1984 May; 36(3):245-52. PubMed ID: 6432287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.